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GeneticsBackground: The association of genotyping information with common traits is not satisfactorily solved.
One of the most complex traits is pain and association studies have failed so far to provide reproducible
predictions of pain phenotypes from genotypes in the general population despite a well-established
genetic basis of pain. We therefore aimed at developing a method able to prospectively and highly accu-
rately predict pain phenotype from the underlying genotype.
Methods: Complex phenotypes and genotypes were obtained from experimental pain data including four
different pain stimuli and genotypes with respect to 30 reportedly pain relevant variants in 10 genes. The
training data set was obtained in 125 healthy volunteers and the independent prospective test data set
was obtained in 89 subjects. The approach involved supervised machine learning.
Results: The phenotype–genotype association was reached in three major steps. First, the pain phenotype
data was projected and clustered by means of emergent self-organizing map (ESOM) analysis and subse-
quent U-matrix visualization. Second, pain sub-phenotypes were identiﬁed by interpreting the cluster
structure using classiﬁcation and regression tree classiﬁers. Third, a supervised machine learning algo-
rithm (Unweighted Label Rule generation) was applied to genetic markers reportedly modulating pain
to obtain a complex genotype underlying the identiﬁed subgroups of subjects with homogenous pain
response. This procedure correctly identiﬁed 80% of the subjects as belonging to an extreme pain pheno-
type in an independently and prospectively assessed cohort.
Conclusion: The developed methodology is a suitable basis for complex genotype–phenotype associations
in pain. It may provide personalized treatments of complex traits. Due to its generality, this new method
should also be applicable to other association tasks except pain.
 2013 Elsevier Inc. All rights reserved.1. Introduction basis of pain has been well established [7–9]. However, so far, asso-Human genotyping information elucidates pathogenetic mech-
anisms and provides clinical guidance for disease management.
However, the association of genotyping information with common
traits is not resolved satisfactorily [1]. Especially in complex traits
emerging from multifactorial mechanisms, single genetic variants
often produce only small effect sizes [2]. This weakens the utility
of genotyping information [1,3].
One of the most challenging traits is pain. It involves a complex
pathophysiology [4] underlying its sensory, affective, motor, vege-
tative and emotional components [5] reﬂected in the large network
of underlying molecular nociceptive pathways [6]. The geneticciation studies largely failed to provide reproducible predictions of
phenotypes from genotypes in the average population [10].
Roughly this is caused by common genetic factors reciprocally can-
celing out their phenotypic consequences [11] and usually exerting
only small effects [12]. To these poor results probably adds that
current analytical methods for genotype phenotype association in
pain are often insufﬁcient. While the complexity of pain is increas-
ingly accepted [13], its high-dimensional phenotypes [14] and
underlying genotypes [11] are mainly subjected to low-dimen-
sional analyses. Indeed, it becomes clear that it is advantageous
to view pain as a complex phenotype when clustering individuals
for their responses to different pain tests [15–17]. However, ap-
proaches applied so far have failed to provide a conclusive solution
to pain genotype–phenotype association problems. This is proba-
bly due to a number of methodological shortcomings. Firstly, the-
oretical reasons suggest that the presently used clustering
techniques should be revised in favor of those that make no prior
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responses across different tests provide no indication of a particular
cluster form. Secondly, clustering approaches used so far have been
restricted to a mere description of the pattern of pain measures
among individuals, without providing analyses of clinically relevant
phenotypes that could be used for predictions by genotypes (for
example, see [16], page 3, Table 1). Thirdly, genotype associations
weremostlymade in separate tests of singlemarkers for phenotypic
effects, without regard to the complexity of the genotypes [11].
Nowadays, more sophisticated bioinformatics tools are available
to successfully approach this complex problem. Besides automated
clustering of complex data, the bioinformatics toolbox also contains
machine leaning methods for a subsequent knowledge-generation
out of the clustering. In the present work, we aimed at developing
a methodology that provides a basis for genotype–phenotype asso-
ciations in complex traits. The methodology was developed to
address several shortcomings of current approaches to genotype–
phenotype associations and was presently applied to the complex
trait of pain. It incorporates the complexity of both pain pheno-
types and pain genotypes and is able to identify subgroups of indi-
viduals with similar pain phenotypes who share genotypic
markers. We show that complex genotypes allow for correct pro-
spective identiﬁcation of up to 80% of the subjects who belong to
a particular pain phenotype cluster. However, as a limited set of
genotypes and phenotypes was used, the intention of this analysis
rather was to pursue a clear methodological focus for the identiﬁ-
cation of complex genotypes and phenotypes and their associa-
tions than to identify new genotypes as a biological explanation
of the observed pain phenotypes.
2. Methods
2.1. Data sources
2.1.1. Study cohorts
The investigations followed the Declaration of Helsinki on Bio-
medical Research Involving Human Subjects and were approvedTable 1
Decision rules (separated by lines) extracted from the CART classiﬁer, providing a
semantic description of the pain phenotypes found by the ESOM/U-matrix cluster
analysis.
Case belongs to IF (rule conditions)
Class 1 IF Heat < 44.55 C
AND Cold > 19.95 C
AND Current < 2.65 mA
Class 2 IF Heat < 44.55 C
AND Pressure < 48.8 N/cm2
Class 3 IF 44.5 6 Heat < 45.5
AND Cold 6 6.35 C
AND Current < 2.25 mA
Class 4 IF HeatP 44.45 C
AND 11.05 C > Cold 6 19.4 C
Class 5 IF HeatP 44.55 C
AND Cold > 11.05 C
AND CurrentP 2.65 mA
Class 6 IF Heat < 44.5 C
AND Cold 6 7.95 C
AND Pressure < 48.8 N/cm2
Class 7 IF HeatP 45.5 C
AND 2.25 mA 6 Current < 4.75 mA
Class 8 IF HeatP 45.5 C
AND Cold 6 6.35 C
AND CurrentP 4.75 mA
HPS: high-pain sensitivity phenotype, APS: average-pain sensitivity phenotype,
LPS: low-pain sensitivity phenotype. : Grouping according to the combined ‘‘Pain’’
variable calculated as the average of all z-transformed pain measures to model the
overall sensitivity to any type of pain stimulus [32].by the Ethics Committee of the Medical Faculty of the Goethe –
University, Frankfurt am Main, Germany. All subjects gave written
informed consent. Exclusion criteria employed were: drug intake
less than seven days previously (except oral contraceptives), actual
clinical pain, and concurrent diseases, based on questioning and a
short medical examination.
Available data consisted of two independent data sets obtained
in two independent study cohorts. The ﬁrst data set, the training
data, had been previously acquired from a random sample of 125
unrelated healthy young Caucasians (69 men, 56 women, mean
age 25 ± 4.4 years) [12,14,18]. At this data set, the genotype–phe-
notype associations were established. To test their prediction, a
new data set was acquired prospectively [19], the test data set,
which was obtained in the same laboratory, from a random sample
of 89 subjects of the same ethnicity and distribution (36 men, 53
women, mean age 25.6 ± 3.9 years).
2.1.2. Phenotyping information
Pain thresholds to four stimuli, including heat, cold, mechanical
and electrical pain, were measured as described previously [14,18].
In brief, heat stimuli were applied using a 3  3 cm thermode
(Thermal Sensory Analyzer, Medoc, Ramat Yishai, Israel) placed
onto the skin of the left volar forearm. While increasing tempera-
ture from 32 C by 0.3 C/s, the subject was requested to press a
button when heat became painful, which was recorded as pain
threshold and subsequently, the thermode was cooled down. Cold
stimuli were applied similarly, however, with temperatures
decreasing by 1 C/s from 32 C to 0 C. Blunt pressurewas exerted
perpendicularly onto the dorsal side of mid-phalanx of the right
middle ﬁnger using a pressure algometer (JTECH Medical, Midvale,
USA) with a circular ﬂat probe of 1 cm diameter. While increasing
the pressure by 9 N/cm2 per second, the threshold was reached
when the subject indicated pain. Electrical stimuli employed were
sine-wave stimuli at 5 Hz, applied via two gold electrodes to the
medial and lateral side of the mid-phalanx of the right middle ﬁn-
ger (Neurometer CPT, Neurotron Inc., Baltimore, MD). As the
intensity of the electrical stimulus was increased from 0 to
20 mA in 0.2 mA/s steps, the subjects were requested to interrupt
the current by releasing a button when perceiving pain. The cur-
rent at which this interruption occurred was the pain threshold.
2.1.3. Genotyping information
Genotyping was done for 20 single nucleotide polymorphisms
(SNPs) [12]. These SNPs and resulting haplotypes, obtained in silico
using PHASE software [20], have been reported previously to mod-
ulate pain [21]. The Hardy–Weinberg equilibrium was preserved in
both cohorts (v2 goodness of ﬁt tests); other details on SNPs and
haplotypes have already been reported elsewhere [12] and are gi-
ven in the Supplemental table to the present publication. Although
restricted, in the light of the currently known >410 ‘‘pain genes’’
[22], the set nevertheless included some major players in nocicep-
tion such as l- and d-opioid receptor genes (OPRM1 [23] and
OPRD1 [24], respectively), transient receptor potential cation chan-
nel genes (TRPV1 [25] and TRPA1 [26]), catechol-O-methyl transfer-
ase (COMT [27,28]), fatty acid amide hydrolase (FAAH [27]),
guanosine 50-triphosphate cyclohydrolase 1 (GCH1 [29]) and vari-
ants of the melanocortin-1 receptor gene (MC1R) associated with
a red-head, -fair-skin phenotype [30,31]. Functional variants were
diagnosed from genomic DNA by means of validated Pyrosequenc-
ing™ assays [12] on a PSQ 96 MA System (Qiagen, Hilden, Ger-
many), with conventionally sequenced samples as controls.
2.2. Data analysis
Analyses were done using Matlab software (MathWorks, Natick,
MS, USA) with functionality expanded by self-developed toolboxes
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nik/software). Besides automated clustering of complex data, the
bioinformatics toolbox also contains machine learning methods
for a subsequent knowledge-generation from the clustering. Data
analysis started with the identiﬁcation of subjects who shared sim-
ilar pain sensitivities to different stimuli. Subsequently, extreme
pain phenotype subgroups (clusters) were analyzed for the under-
lying complex genetic architecture. Finally, the complex genotype
was used to identify those subjects from the test data set who
had belonged to a similar pain subgroup.
2.2.1. Analysis of the pain data cluster structure
2.2.1.1. Data exploration and preprocessing. Data was z-transformed
and a combined ‘‘pain’’ variable, zTotalPain, was calculated as the
sum of all rescaled pain measures to model the overall sensitivity
to any type of pain stimulus [32]. This combined data was split into
three classes of pain sensitivity (Fig. 1), i.e., ‘‘low pain’’ sensitivity
(LPS; zTotalPain 6 s), ‘‘average pain’’ (APS, zTotalPain in the inter-
val [s, s]) and ‘‘high pain’’ (HPS, zTotalPainP s). This corresponds
to a classiﬁcation with thresholds ± s at 20% and 80% of the distri-
bution and reﬂects the previous classiﬁcations of LPS, APS and HPS
phenotypes by Diatchenko et al. [32].
2.2.1.2. Projection and clustering pain data. This analysis focused on
identifying subjects with similar pain phenotypes. The distribu-
tions of the phenotypical pain data turned out to be rather complex
(Fig. 1). These distributions could be modeled with a mixture of
three Gaussians N(mi, si), i = 1, 2, 3. The theorem of Bayes allows
to calculate posterior probabilities p(i|x), i.e., the probability that
for a given pain value x the data belongs to Gaussian i. The value
B = p(3|x)  p(1|x) takes a value of 1 if x belongs to Gaussian 3, aFig. 1. Gaussian Mixture Models (GMM) of the pain variables. Blue is the measured emp
GMM as sum of the three Gaussians shown in magenta. The vertical green lines indicate t
is that these boundaries are similar to the CART decision rule boundaries of Table 1. The m
Gaussians N(mi, si), i = 1, 2, 3 (black line including the three individual Gaussians in mag
probability that for a given pain value x the data belongs to Gaussian i (green lines). (For i
the web version of this article.)value of 0, if x belongs to Gaussian 2 and 1 if x belongs to Gauss-
ian 1. For the subsequent projection and clustering as measure of
‘‘similarity’’, the Euclidian distance of the B values was used. Each
person’s response to the pain stimuli (n = 4 dimensions), plus the
overall sensitivity score (n = 1 dimension), was treated as a point
in a ﬁve-dimensional Euclidean vector space (data space).
To obtain clusters in this vector space, the data was projected
onto a two-dimensional plane. This space is called a map with a
geographical interpretation in mind. As classical projection algo-
rithms, such as principal component analysis or multidimensional
scaling, cannot preserve complex cluster structures, the ESOM/U-
matrix method was used [43]. ESOM clustering provides a number
of advantages over alternative methods, such as K-means or Ward,
the most relevant one being the lack of prior assumption about the
cluster structure.
Using ESOM, data was projected onto a two-dimensional bor-
derless grid (map space) of 50  82 = 4200 units (‘‘neurons’’;
Fig. 2). The map space is toroid [33] and the projection is neighbor-
hood preserving [34]. I.e., points that are neighbors in the high
dimensional data space are also neighbors on the map space. Each
neuron holds a vector of ‘‘weights’’ of the same dimension as the
ﬁve input dimensions (four z-transformed pain thresholds plus
the combined pain variable) in the input space. The weights ini-
tially were randomly drawn from the range of the data variables.
In an adaptation process, (learning phase, 100 epochs) they were
adapted to the data (training cohort, n = 125). As learning and test
data had been obtained in the same laboratory with the same
equipment, it was expected that test data could be included in
the map, which was veriﬁed by constructing the ESOM with all
the data. The Adjusted Rand Index (ARI) [35] of a clustering using
only the training data set compared to a clustering of all data isirical probability density using Pareto Density Estimation (PDE). Black indicates the
he decision boundaries according to the theorem of Bayes. An additional observation
easured probability densities (blue lines) could be modeled with a mixture of three
enta). The theorem of Bayes allows to calculate posterior probabilities p(i|x) i.e. the
nterpretation of the references to color in this ﬁgure legend, the reader is referred to
Fig. 2. U matrix three-dimensional view, with a geographical interpretation in
mind (for technical details of the presentation, see http://www.uni-marburg.de/
fb12/datenbionik/forschung/esom), showing the clustering of subjects with com-
parable pain phenotypes as obtained using emergent self-organizing map (ESOM).
The clusters were visualized using a U-matrix [36], which is a representation of the
distances in data space on top of a map space. The U-matrix was cut from a tiled
display of the ESOM to remove duplicate representation of the data. It was colored
as a geographical map with brown or snow-covered heights and green valleys. High
‘‘walls’’ in a U-matrix indicate large distances between the pain responses of the
125 persons. Points represent persons and their coordinates in the toroid map space
are used to address them when querying information. Points, or ‘‘persons’’, that lie
together in a valley of the U-matrix indicate that these persons have a common
response type pattern in all ﬁve stimuli. Thus, these valleys indicate clusters of pain
types. The watersheds of the U-matrix indicate borderlines of clusters. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
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of the cluster structure in the training and the test data.
2.2.1.3. Visualizing pain phenotype clusters. Data on the trained
ESOM was presented on the two-dimensional toroid map where
a cluster structure was to be visualized. This was obtained by add-
ing a third dimension consisting of the average distance of the
weight vector of a neuron to the weight vectors of its direct neigh-
bors, which is known as the U-matrix [36]. Speciﬁcally, the U-ma-
trix is a representation of the distances in data space on top of the
map space (Fig. 2), with a geographical map analogy in mind. The
watersheds of the U-matrix show borderlines of these pain clus-
ters, i.e., high ‘‘walls’’ between data points indicate large distances
between individual pain responses. By contrast, points lying to-
gether in a valley of the U-matrix represent persons who have a
common pain response pattern with respect to the four stimuli
and the overall sensitivity score. Cluster visualization was further
enhanced by calculating the U matrix, which results from the
combination of the U-matrix distances with the P-matrix. The lat-
ter also uses the ESOM map as a ﬂoor space layout, however, in-
stead of the local distances, density values in data space
measured at the neuron’s weights are used as height values [33].
The process was performed using the ESOM toolbox [37], publicly
available at http://www.uni-marburg.de/fb12/datenbionik/soft-
ware (accessed on March 17, 2013).
2.2.2. Identiﬁcation of classiﬁers for pain phenotypes
The ESOM/U-matrix clustering identiﬁed the subjects who had
similar pain sensitivities. However, the result was still a ‘‘black
box’’ with respect to the pattern of particular pain thresholds
shared by the cluster members. Therefore, the subsequent analysis
aimed at obtaining clear descriptions, in terms of pain thresholdmarkers, of the sensitivity patterns, thus obtaining pain phenotype
groups (clusters) in the training data cohort. The cluster structure
obtained with the U-matrix was interpreted by extracting the deci-
sion rules, in terms of measured stimulus intensities at the pain
thresholds, from a classiﬁcation and regression tree (CART) classi-
ﬁer that assigned each subject of the training set to a particular
pain cluster (Table 1). A random sub-sampling validation with
125 data sets for the construction of a CART decision tree and 81
data sets for testing repeated 50 times resulted in a mean accuracy
of 95.5% with a standard deviation of 1.4% of the classiﬁer. This is
consistent with the CART classiﬁcation accuracy of 95% of the split
into training and test data set as given above. CART provides a sim-
ple and easy understandable form of the classiﬁcation rules and
effectively uses the conditional information of the GINI index
[38] to ﬁnd optimal (local) dichotomic decisions. Furthermore,
CART is invariant under transformations of the variables, robust
with respect to outliers and allows estimation of the misclassiﬁ-
cation rate [38]. The requirements for this classiﬁer are that it is
sufﬁciently able to perform the classiﬁcation task and that the clas-
siﬁcation is based on rules that a human reader can understand
(knowledge). As shown below the decision rules can be used for
a very precise deﬁnition of the cluster’s ‘‘meaning’’.2.2.3. Identiﬁcation of genotypic associations
2.2.3.1. Marker pre-selection. Associations were sought that would
identify a positive or negative combination (i.e., a rule) for the 29
genetic variables (labels) that described extreme pain phenotype
clusters as well as possible. Speciﬁcally, the 29 genetic markers
for each subject were labeled with a ‘‘Yes’’ (=1), ‘‘No’’ (=1) or
‘‘Don’t care’’ (=0), modeling in the presence, absence or insigniﬁ-
cance of the reportedly functional allele. In addition, sex was coded
as +1, if female and 1 if male. To search for such rules in all vari-
ables means regarding a space of size R = 330 > 2.0  1014. A com-
plete search in this space is out of the processing time range of
current personal computers. Therefore, the genotypes had to be
preselected. This was achieved in a 100-fold repeated cross-valida-
tion experiment (80/20 split), on three blocks consisting of 10 ge-
netic markers each. In these blocks those combination of markers
were selected that were useful to predict the HPS/LPS dichotomy
with an accuracy of at least 71%. This greedy search reduced the
search space to 314 > 4.7  106 potential candidates for rules,
which is possible to explore in feasible computing time (ca. 2 h
on a typical PC). The reduced set of 14 genotype markers, thus
identiﬁed, was subsequently used to construct predictive complex
genotypes.2.2.3.2. Associating complex genotypes with pain phenotypes of
interest. The preselected genetic markers and the subject’s gender
were submitted to a machine learning procedure called ‘‘Un-
weighted Label Rule generation’’ (ULR) [39]. This tested all possible
additive combinations of the 29 genetic markers and of gender for
the best prediction of the membership of the extreme pain clusters
in the training cohort. The possible sum of the markers consisted of
the genetic markers (present, 1, absent, 0) multiplied by 1, 1 or 0.
ULR ﬁrst tested all single-label rules (R = 60) and measured the
performance of the rule to predict the membership of the subject
of the selected pain cluster as the area (AUC) under the receiver
operating characteristic (ROC) curve [40]. It then combined the
best performing one-variable rules. All possible sums of variables
were tested.
For all resulting ULR rules, AUC, sensitivity and speciﬁcity were
calculated. The performance of each rule was compared with that
of the best guessing rule, which means just assigning all cases to
the larger class of the dichotomy. If a ULR provided at least 5% bet-
ter prediction performance than the best guess, it was included as a
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the best AUC using the least number of labels was ﬁnally selected.
2.2.4. Assessment of the predictive performance of phenotype and
genotype markers
After having identiﬁed both pain phenotype clusters and the
underlying genetics in the training data set, the obtained knowl-
edge was applied to the test data set.
2.2.4.1. Predicting pain cluster membership from phenotypic mark-
ers. The decision rules obtained with the CART classiﬁer (Table 1)
provided characteristics of pain cluster membership of the training
data. The rules were subsequently applied to the test data to assess
their performance to assign an individual subject to a particular
pain phenotype, based on the information of four individual pain
thresholds and the overall pain sensitive score.
2.2.4.2. Predicting pain cluster membership from genetic mark-
ers. Pain phenotype groups of major interest for genetic predic-
tions were considered to consist of those containing subjects at
the extreme of the distribution, with either very high or very low
pain sensitivity. The predicted genetic causes of high or low pain
sensitivity can then be considered as reasonable drug targets for
pain therapy. To emphasize extreme pain phenotypes, ESOM clus-
ters were intersected with the HPS/APS/LPS providing groups
which were homogeneous with respect to their sensitivity to single
stimuli grouping, while at the same time sharing the same extreme
overall pain sensitivity (Table 2).
Subsequently, the composed genotype obtained by means of
ULR of the training data set was searched in the test data set.
The performance assessed whether this correctly identiﬁed the
subjects belonging to either the low or high pain threshold groups
in the test data set.
3. Results
3.1. Pain phenotypes
The ESOM clustering of the pain data and subsequent visualiz-
ing provided a U-matrix (Fig. 2) in which eight pain phenotypes
could be observed (Fig. 3B), comprising individuals who shared
complex pain threshold patterns across the four different noxious
stimuli (i.e., heat, cold, electrical current and blunt pressure) andTable 2
Grouping of all subjects according to similarities in pain perception. The columns
show the grouping according to the combined ‘‘Pain’’ variable, calculated as the
average of all z-transformed pain measures to model the overall sensitivity to any
type of pain stimulus [32]. This deﬁned three subgroups of pain sensitivity: high-pain
sensitivity (HPS) phenotype, average-pain sensitivity (APS) phenotype and low-pain
sensitivity (LPS) phenotype [32]. The lines show pain groups (clusters) from the
ESOM/U-matrix clustering (Fig. 3). Subjects with extreme phenotypes (high pain
sensitivity, i.e., the intersection of the HPS group with ESOM clusters 1 and 2; low
pain sensitivity, i.e., the intersection of the LPS group with ESOM clusters 7 and 8)
were chosen to demonstrate the prediction of extreme phenotypes by complex
genotypes (italicized table cells).
ESOM cluster (class) # HPS APS LPS n (%)
Pain subgroup
1 20 2 0 22 (10.7)
2 12 1 0 13 (63.1)
3 2 47 2 51 (24.8)
4 2 28 0 30 (14.6)
5 3 11 0 14 (68)
6 2 9 0 11 (53.4)
7 0 18 15 33 (16)
8 0 7 25 32 (15.3)
n (%) 41 (19.9) 123 (59.7) 42 (20.4) 206 (100)the combined pain score (average of the z-values). The speciﬁc
properties characterizing each phenotype, as derived from the
CART classiﬁer (Table 1), could be interpreted clinically. For exam-
ple, those belonging to cluster 7 and 8 were both stoical towards
thermal pain. Individuals in cluster 7 were average sensitive to cur-
rent pain stimuli while those belonging to cluster 8 were neither
cold nor current sensitive. On the other side, subjects belonging
to cluster 1 were generally highly temperature sensitive. Those in
cluster 2 were also very pressure sensitive. The CART decision rules
allowed for the prediction of the cluster membership in the test
data set with an accuracy of 95%. The cluster structures were sim-
ilar in the training and test data sets. Speciﬁcally, the CART classi-
ﬁer created from the training data predicted the cluster
membership of the test data set with an accuracy of 95%.HPS LPS
APS
HPS
LPS
C
Fig. 3. Bird’s view of the U matrix shown in Fig. 2. In the top panel (A), the map
space is presented analogously to a physical map with a geographical map analogy
in mind. Dots indicate the single individuals, with green and red dots emphasizing
the HPS and LPS groups, respectively, as emphasized in panel C. Below this map (B),
in the middle panel, the eight ESOM/U-matrix clusters 1–8 (Table 1) are indicated
analogously to a political map. In the bottom panel (C), another ‘‘political map’’
emphasizes the HPS/APS/LPS pain groups [32]. A comparison with map B shows
that the HPS and LPS were mainly composed of subjects belonging to ESOM clusters
1/2 or 7/8, respectively. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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with the classiﬁcation into three major phenotypes [5], namely,
‘‘low pain sensitivity’’ LPS (n = 41), ‘‘average pain’’ (APS, n = 123)
and ‘‘high pain’’ (HPS, n = 42). For example, the LPS group was
formed mainly of subjects belonging to ESOM classes 7 and 8.
However, while all subjects of classes 7 and 8 were stoical towards
heat, only subjects of class 8 were also stoical towards cold (Ta-
ble 1), emphasizing the greater complexity of ESOM clustering.
Similarly, the HPS group consisted mainly of subjects belonging
to ESOM classes 1 and 2. However, while all HPS subjects were sen-
sitive to heat, those belonging to cluster 1 were also sensitive to
cold, i.e., completely temperature sensitive, whereas those belong-
ing to cluster 2 were pressure but not cold sensitive.
3.2. Genotype–phenotype associations
In a cross-validation experiment, repeated 100 times, 14 genetic
variables including ‘‘gender’’ were identiﬁed that had sufﬁciently
high accuracy (> 71%) for the training data set. These preselected
genetic markers and the subject’s gender were submitted to a
ULR machine learning procedure aimed at identifying the marker
combinations that best predicted the subjects’ pain phenotype.
Thus, a rule space of size R = 314 > 4.7  106 was searched in order
to predict membership of the low or high pain thresholds clusters,
which were deﬁned, respectively, as the intersections between (i)
ESOM clusters 1/2 and the HPS phenotype, or (ii) ESOM clusters
7/8 and the LPS phenotype (Table 2).
ULR generated the following rule for membership of the
low pain threshold clusters: If (+COMT rs6269G + TRPA1rs
13255063A/rs11988795G + TRPA1 rs13255063T/rs 11988795G +
FAAHrs324419C/rs2295633A + Sex(+1) if female, (1) if male  COMT
rs6269A/rs4633T/4818C/rs4680A  COMT rs4646312T/ rs 165722
C/rs6269A/rs4633C/rs4818C/rs4680G  OPRM 1 rs 1799971G
 FAAH rs324419T/rs2295633A  GCH1‘‘pain protecting haplotype’’ rs800
7267A/rs3783641T/rs10483639G1 MC1Rredhead genotype) > 0.5 then
the case belongs to the intersection of ESOM/U-matrix cluster 1 and 2
with the HPS phenotype, i.e. to the pain phenotype subgroup with a
very high pain sensitivity and not to the opposite phenotype clusters.
Each component of this rule denotes presence or absence of the
respective functional genotypic markers (0, 1) carried by the subject.
In the training data set, this rule predictedmembership for an individ-
ual of either low or high pain threshold clusters with an accuracy of
78%. The rule uses – apart from gender-only eight genetic markers.
Subsequently, the combined genotype was identiﬁed in sub-
jects belonging to the test cohort. It predicted membership for an
individual of either low or high pain threshold clusters with an
accuracy of 78%. For comparison, among single genetic markers
and gender, only the latter provided a prediction better than guess-
ing, i.e., assigning all subjects just to the larger group of two alter-
natives. However, gender provided only a predictive accuracy of
67%.
4. Discussion
In this study, we employed the whole cycle of machine-sup-
ported generation of presumably new knowledge (hypothesis gen-
eration) from complex high-dimensional data. Firstly, the
inspection involved clustering of high dimensional phenotype data
(ESOM/U-matrix). In a second step, this clustering of data was used
to generate a (cross-validated) classiﬁer (CART) which uses explicit
rules for the classiﬁcation. These rules are understandable and1 As discussed previously [29], although the pain protective haplotype originally
comprised 15 GCH1 SNPS, it can be identiﬁed with 100% accuracy by genotyping only
the three variant alleles rs8007267A, rs3783641T and rs104836c39G [41], at least in
caucasian subjects with the present origin [29].interpretable by humans. The rules were found to be consistent
with previous work (LPS/APS/HPS [32]) and gave hints to a more
complex structure of human pain sensation types (8 classes). This
classiﬁcation was used for the generation of a classiﬁer of the geno-
type data. The methodology mapped the genetic architecture of
subjects sharing a particular pain phenotype and predicted, on
the basis of a complex genetic marker, their membership of this
phenotype in an independent cohort with an accuracy of almost
80%. This indicates that ESOM/U-matrix-based clustering, with
subsequent rule generation, is suitable to provide pain phenotypes
that are carried by subjects sharing a common pain-relevant genet-
ic background [11].
ESOM clustering makes no prior assumption about the cluster
structure. This is a major advantage of the present method over
previous attempts to cluster pain phenotypes [15–17] that may
have missed relevant pain clusters or provided wrong individual
cluster associations by superimposing a possibly inadequate
cluster structure on the data. In addition, the proposed method
exceeds previous approaches towards genotype–phenotype asso-
ciation in several further ways. Whereas other approaches
stopped after the phenotype classiﬁcation had been obtained,
the present method continued at this stage with a machine learn-
ing algorithm that generated decision rules for each cluster, pres-
ently implemented using CART, C4.5 [42]. The aim of this
approach was to gain a suiting ROC AUC (>0.8) and an under-
standable semantic description of a cluster. This provides a suit-
able basis for clinically relevant phenotype clustering and
subsequent genotype associations. This was not included in previ-
ous approaches, even though, from a bird’s eye view of the com-
prehensive display of the cluster averages (Fig. 2 of [17]), it can be
seen that cluster number 2 could possibly be determined by the
single variable ‘‘high sensitivity to spontaneous pain attacks’’.
Similarly, ﬁve distinct clinical phenotypes of neuropathic pain
[17] were obtained by means of hierarchical cluster analysis, in
a classical approach from the patients’ self-estimations of sponta-
neous and evoked pain. None of the clusters was described in any
way. The same applies to the ﬁndings of Hastie et al. [15] who
found that pain has distinct dimensions, leading to complex phe-
notype clusters. Four principal factors were derived from heat,
pressure, ischemic pain and temporal summations of pain stimuli.
Using hierarchical cluster analysis of 188 cases, four distinct
groups were found, based on patterns of responses across multi-
ple pain stimuli [15]. Cluster (i), ‘‘high pain sensitivity’’, partly
coincides with the present ESOM clusters 1 and 2 [28].
Previous attempts to describe pain phenotypes that acknowl-
edged the complexity of pain only incompletely extended this to
genotyping information [43]. However, introducing complex
genotypes is required [11] to obtain a successful genotype–phe-
notype association, which single genetic markers cannot provide
[10,44]. This is because of the small effect size that was exerted
through the genetic markers on the phenotype measures, which
had already been shown in the present training data set [12].
Speciﬁcally, the values of Cohen’s d for the effects of the 30
genotype markers on single pain threshold measures were lower
than d = 0.2 (small) in 80% of the marker-threshold associations
and only in 2% of the associations greater than d = 0.5 (medium).
Using single markers on low versus high pain threshold clusters
already provided increased effect sizes with 50% of the Cohen’s d
values >0.2 (small) and 12% > 0.5 (medium). However, a dramatic
increase in effect sizes was obtained when using combined
rather than single genetic markers. Thus, the composed ULR
genotype provided values of Cohen’s d = 1.25, 1.35, 0.63 and
1.33 for heat, cold, pressure and electrical stimuli, respectively,
for subjects belonging to either low or high pain threshold clus-
ters (Table 2). An effect size is usually considered to be large, if
Cohen’s d > 0.8.
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ously reported positive ﬁndings which, however, may implicitly be
inﬂuenced by other non-accounted for variants [11], contain
never-reproduced associations and often be based on weak biolog-
ical bases. Therefore, the interpretation of variants expected to be
present or absent in highly pain-sensitive subjects should be done
with caution. Consistent with these expectations, the negatively
inﬂuential GCH1 haplotype was originally reported to be pain pro-
tective [45]. This is biologically plausible as this haplotype impedes
GCH1 up-regulation, followed by reduced availability of the pro-
nociceptive tetrahydrobiopterin [29]. The fact that the COMT
rs6269A/rs4633T/rs4818C/rs4680A haplotype, associated previ-
ously with average, but not with high pain sensitivity (APS) [28],
received a negative connotation in our study is also consistent with
expectations. A further agreement with expectations is the positive
inﬂuence of female gender, as in women, higher pain sensitivity
than in men has been identiﬁed in most gender studies on pain
(for reviews, see [46–48]). However, the roleMC1R genotype is less
clear, as subjects carrying non-functional MC1R were reported to
exhibit an increased tolerance to electrical pain stimuli [30], but
this was not reproduced [31] and occasionally contradicted [31];
the latter outcome ﬁtted best to the high-pain rule found in our
study. However, the biological, mechanistic basis ofMC1R pain reg-
ulation is not yet completely clear. In contrast to expectations,
OPRM1 rs1799971 A > G, which has been associated with de-
creased nociception [49,50], was allocated a positive inﬂuence.
However, the molecular basis of this association is questionable
since the increased afﬁnity of endorphin at N40D l-opioid recep-
tors [51], related to this genotype, with subsequent reduced activ-
ity of the endogenous nocifensive opioid system, could not be
reproduced [52–54]. Moreover, the variant is well known to reduce
opioid receptor signaling efﬁciency [52] and expression [53–55],
including a genetic–epigenetic interaction impeding receptor up-
regulation [56]. Therefore, its inclusion in lower pain threshold
cluster predictions is biologically plausible. Further components
of the genotypes are difﬁcult to interpret on basis of previous ﬁnd-
ings, as they have been reported to be associated with changed
pain sensitivity [27], without specifying the direction of that
change.
After the successful development and veriﬁcation of the present
methodology for pain phenotype–genotype association, the analy-
sis cannot be extended beyond the prediction of extreme pheno-
types from combined genetic markers. A ﬁnal characterization of
human pain could not be expected as the data set was limited by
the numbers of cases, pain markers and genetic markers. Currently,
at least 410 pain genes have been established [9], for example, 390
‘‘pain genes’’ are found in the PainGenes database [57] at http://
www.jbldesign.com/jmogil/enter.html (accessed on April 4,
2013). The inclusion of a more comprehensive set of genetic mark-
ers is very likely to change the set. With genome-wide data, there
is no impediment to the replacement of the ULR based generation
of complex genotypes by ESOM/U-matrix based genotypes and this
option is opened by the present methodology. Psychological fac-
tors also may be included, but again, the methodology is now
available.
The present results show that machine-learned knowledge-
generation from identiﬁed phenotype structures is suited for asso-
ciating underlying biomarkers. The method exceeds the currently
available pain genotype–phenotype association methods in several
ways. Most importantly, the high-dimensionality of both pain phe-
notype and pain genotype is taken into account by the present
ESOM/U-matrix-based cluster identiﬁcation, CART rule-based phe-
notype extraction and ULR-based genotype association. Thus, the
present methodology appears able to resolve the poor clinical util-
ity of current genotyping information for pain management [10],
by providing larger effect sizes of combined genetic as comparedto single genetic markers and by preselecting subjects with similar
pain phenotypes who are more likely to share pain-relevant geno-
types. The key to successful approaches to personalized pain ther-
apy seems to lie less in the identiﬁcation of more and more factors
but in the combination of the high-dimensional information by
informatics methods. Provided accessibility to large pain pheno-
type and genotype data sets is possible, the present methodology
may provide the basis for genetics-based personalized pain treat-
ment. The approach thus satisﬁes the complexity of pain and ex-
ceeds by far the so far available pain genotype–phenotype
association methods. This new method should be applied to larger
data sets to ease the clinical utility of genotyping information for
pain research and therapy. Due to its generality, this new method
should also be applicable to other association tasks apart from
pain.
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